In diabetes mellitus, water turnover in the body is enhanced because of the glucose-induced osmotic diuresis and it is usually assumed that the concentrating capacity of the kidney is partially impaired. On the other hand, plasma vasopressin concentration is known to be increased by several fold in patients with Type I (insulin-dependent) diabetes mellitus or Type II (non-insulin-dependent) diabetes mellitus as well as in animal models of experimental or genetic diabetes mellitus [1±6]. This high vasopressin concentration is accompanied by a desensitization of V1 a receptors in liver, kidney and platelets [7, 8] . In contrast, renal V2 receptors, responsible for the antidiuretic action of the hormone, are not down-regulated [8] .
for the urinary excretion of a much increased load of solutes (due in large part because of glucose wastage). Recent studies have revealed that the diabetic kidney displays an increased (not a decreased) urinary concentrating activity. Although urine flow rate is much increased and urine osmolality modestly decreased, the amount of free water that the kidney reabsorbs in order to excrete the actual load of solutes, the solute-free water reabsorption, is largely enhanced in diabetes mellitus [9, 10] .
The influence of vasopressin on urinary concentrating activity is largely because of the effect of this hormone on the permeability of the collecting duct (CD) to water, depending on the vasopressin-regulated water channel aquaporin-2 (AQP2). It is also critically dependent on the accumulation of urea in the inner medulla which is made possible by the presence, in the terminal part of the CD, of a vasopressin-dependent urea transporter, UT-A1. This transporter allows urea to diffuse into the inner medullary interstitium, thus feeding urea continuously to the deepest part of the medulla. In addition, medullary urea, which might escape this region by ascending the vasa recta, is returned to the inner medulla by countercurrent exchange in descending thin limbs and vasa recta endowed with facilitated urea transporters (UTs) UT-A2 and UT-B1, respectively [11±15] . Both UT-A1 and UT-A2 are expressed exclusively in the kidney and are encoded by differential transcription from the same gene. Both UT-A2 and UT-B1 are present on the luminal and the basolateral membranes along a limited length of thin descending limbs (TDL) for UT-A2 [16] and in the endothelium of descending vasa recta along most of their length for UT-B1 [17] .
Because of the unique situation encountered in diabetes mellitus, with, simultaneously, a large increase in both urine flow rate and vasopressin-dependent water reabsorption, it was interesting to see whether this disease is associated with alterations in the expression of AQP2 and of the urea transporters involved in the urinary concentrating process. Our experiments were designed to better characterise the relative amounts of the different solutes that are concentrated in the urine of diabetes mellitus rats and to evaluate, in the same rats, the changes in AQP2 and urea transporter mRNA or proteins occuring in diabetes mellitus.
Material and methods
Animals and induction of diabetes mellitus. Principles of laboratory animal care were followed. Adult male Wistar rats (Iffa Credo, Lyon, France) were used. Because diabetes slows the increase in body weight with time, those rats which were to be made diabetic weighed 50 g more than control rats at the start of the experiment, so that they would reach similar body weights at the time of killing. Rats were allowed free access to tap water and regular rat food (M5, Extralabo, Provins, France), containing 23 % protein, during the entire experiment. Different rats were used for northern and western blot analysis.
Diabetes was induced by a single intraperitoneal injection of streptozotocin (STZ) (Sigma, St Louis, Mo., USA), 65 mg/ kg body weight, freshly dissolved in 0.1 mmol/l citrate buffer, pH 4.5. Control (CO) rats were injected with vehicle alone. Two days later, diabetes was confirmed by measuring the presence of glucose in urine. Two weeks after the streptozotocin (STZ) injection, rats were placed in individual metabolic cages for 1 week and urine was collected for the last 2 days (2´24 h). Urinary flow rate, osmolality and glucose and urea concentrations were measured. Rats were killed 3 weeks after streptozotocin or vehicle administration. This duration of diabetes mellitus was chosen because several parameters perturbated by the initiation of diabetes mellitus reach a steady state 2 weeks after STZ injection [9] . Rats were anaesthetised with pentobarbital and a blood sample was collected from the jugular vein. Blood glucose was measured with One-touch-two (Life-Scan, Issy-Les-Moulineaux, France), plasma and urine osmolality with a freezing-point osmometer (Roebling, Berlin, Germany), glycosuria with a Glucose kit (Trinder, Sigma, St Louis, USA), and plasma and urine urea concentrations with a Urea kit (BioMØrieux, Lyon, France). Solute-free water reabsorption was calculated according to the following formula: T c H2O = ((Uosm/Posm)´urine flow rate)±urine flow rate Dissection of renal medulla subzones. Because urea transporters are not expressed in the renal cortex and outer stripe of the outer medulla, only the inner stripe of outer medulla (IS) and the inner medulla (IM) were studied. In these two zones, urea transporters are not expressed homogeneously. In IS, UT-A2 has been localized in the deep but not in the superficial half of thin descending limb (TDL) of short loops of Henle [14, 16, 18] . In IM, facilitated urea transport has been shown in the terminal but not in the initial inner medullary collecting duct (CD) (IMCD) [19] and UT-A1 mRNA have been localized in IM tip but not in IM base [18] . Accordingly, in this study, IS and IM were each divided into two subregions to allow a more precise spatial analysis. Kidneys were removed, weighed and sliced. For both northern blot and western blot experiments, representative tissue fragments (15±50 mg) of the upper and lower halves of IS (superficial and deep IS, respectively) and of the upper third and the lower two thirds of IM (base and tip, respectively) were dissected from kidney slices at 4 C under stereomicroscopic observation.
Northern blot analysis of urea transporters. Northern blot analysis was done in 5 diabetic rats and 4 control rats. Total RNA was extracted from homogenised tissue fragments by a simplified guanidium thiocyanate procedure (RNA NOW, Biogentex, Seabrook, USA). Quantification of UT-A1 and UT-A2 mRNA was done using a rat clone of 771 bp which reveals UT-A1 as a 4.0 kb-transcript, and UT-A2 as a 3.0 kb-transcript [20] . The UT-B1 mRNA was revealed by a rat clone of 1200 bp [21] . Probes were radiolabeled by the random-priming technique (Megaprime labeling kit, Amersham, Les Ulis, France) using [a-32P] dCTP, to a specific activity of 2´10 9 cpm/mg cDNA. The RNA samples (5 mg) were denatured and separated by electrophoresis on agarose gel (1.0 %) containing 0.6 mol/l formaldehyde. The RNAs were transferred overnight from gel to nitrocellulose membranes (Hybond C-Extra, Amersham, Ulis, France) which were then baked in a vacuum oven (2 h, 80 C). Blots were placed in glass hybridization tubes containing 10 ml medium composed of 5´SSPE (see composition below), 50 % formamide, 0.5 % sodium dodecyl sulphate (SDS), 1 mg/ml bovine serum albumin, 1 mg/ml Ficoll 400, 1 mg/ml polyvynylpyrrolidone, and 40 mg/ml denatured salmon sperm DNA. Prehybridization was done at 42 C for 4 h in a hybridization oven. Then, the radiolabeled probe was added to prehybridization medium (4´10 6 cpm/ml), and membranes were incubated overnight at 42 C. Blots were washed twice at 23 C in 2´SSPE, 0.1 % SDS for 15 min and once at 32 C in 1´SSPE, 0.1 % SDS for 30 min. The final wash was carried out at 55 C for UT-A1 and UT-A2, and 42 C for UT-B1, in 0.1´SSPE, 0.1 % SDS, 30 min. The composition of 1´SSPE was 150 mmol/l NaCl; 10 mmol/l NaH 2 PO 4 ; 1 mmol/l EDTA; pH 7.4. Blots were exposed for 2 to 4 days to autoradiographic film (Hyperfilm-MP, Amersham) with intensifying screens, at ±80 C. The membranes were then hybridized to a cDNA probe of mouse b-actin [22] . Expression of mRNA was quantified by densitometry (Deskan II and ScanAnalysis, Biosoft, Palo Alto, Calif., USA) after scanning of the autoradiograms (Scan Jet, Hewlett Packard, Les Ulis, France). The abundance of urea transporter mRNAs was expressed relative to that of b-actin in the same samples. The b-actin mRNA expression per mg total RNA was not different between the diabetic and control rats.
Antibodies. A purified rabbit polyclonal antibody against a Cterminal 19 amino acid sequence common to rat UT-A1 and UT-A2 was purchased from Alpha Diagnostic International (San Antonio, USA). Rabbit polyclonal antibodies against UT-B1 and AQP2 were prepared by Neosystem (Strasbourg, France), using as antigens synthetic peptides from the N-terminus sequence of rat UT-B1 (MEDIPTMVKVDRGESQILST), and from the C-terminus sequence of rat AQP2 (CEL-HSPQSLPRGSKA). These have been characterised elsewhere [23, 24] .
Western blot analysis of AQP-2 and urea transporters. Western blot analysis was done in 4 diabetic rats and 4 control rats. Tissue fragments from the four medulla subzones were thoroughly homogenised in 0.5±1.0 ml ice-cold lysis buffer (250 mmol/l sucrose, 10 mmol/l triethanolamine, pH 7.6) containing 1 mg/ ml leupeptin and 100 mg/ml phenylmethylsulphonylfluoride. Protein concentration of the crude homogenates was measured with a BCA protein assay reagent kit (Pierce, Rockford, USA). Protein concentration was adjusted to 3 mg/ml with lysis buffer. Altogether 15 mg protein of each crude homogenate were separated by electrophoresis on denaturing SDS/10 % polyacrylamide minigels. Proteins were transferred electrophoretically overnight to a polyvinylidene difluoride membrane (NEN, Boston, Mass., USA). Blots were blocked for 1 h at room temperature with 5 % non-fat milk in PBS containing 0.3 % Tween-20. Blots were incubated for 2 h at room temperature with either UT-A antibody (0.5 mg/ml) or UT-B1 antibody (1:2000 dilution of the antiserum). After washings, they were incubated for 1 h with the second antibody (goat antirabbit immunoglobulin G) conjugated with horseradish peroxidase (Promega, Madison, USA). Specific proteins were revealed by enhanced chemiluminescence (NEN, Boston, Mass., USA). The pre-immune serum of the rabbit used for the UT-B1 antibody production was checked on a control blot and gave no labelling. Equal protein loading was verified by Coomassie blue staining of the membranes at the end of the experiment.
Statistics. Results are expressed as means SEM. Differences between groups were analysed by Student's t test. They were considered significant for a p of less than 0.05.
Results
Diabetic rats exhibited the expected hyperglycaemia, increase in osmolar excretion and renal hypertrophy. The high plasma osmolality was mainly due to glucose but urea concentration was also higher (Table 1). The urine flow rate increased by almost ninefold and urinary osmolality slightly decreased. Nonetheless, solute-free water reabsorption, the most ap- Values are means SEM of 8 control and 10 diabetes mellitus rats (* n = 5 rats only) BW = body weight propriate index of the concentrating effort of the kidney, was considerably increased (from 61 to 269 ml/ day). This is explained by the fact that the load of osmoles concentrated in the urine is much larger in diabetic rats than in control rats ( 6.1) ( Table 1 ). The rise in osmolar excretion was mostly due to glucose which was absent in the urine of normal rats and represents as much as 58 % of urinary solutes in diabetic rats. Moreover, an increase in urea excretion ( 2.3) resulting from the diabetes-associated hyperphagia also contributed to the increased osmolar excretion. It is to be noted, however, that urea represented only 15 % of total solutes in diabetes mellitus compared with 47 % in control rats and that its relative concentration in urine with respect to plasma (urine/plasma ratio) was fivefold lower in diabetic rats than in control rats (19 vs 93) . Relative glucose concentration (urine/blood) in diabetic rats reached 21 (Table 1) . Thus, in diabetes, glucose becomes the largest osmotic substance in the urine and is strongly concentrated. In contrast, urea becomes a smaller fraction of total urinary osmoles and its relative concentration is reduced when compared with control rats.
Expression of Aquaporin 2. The abundance of AQP2 protein increased in all subregions of the medulla of diabetic rats when compared with control rats (Fig. 1) . These changes were more pronounced in IS than in IM (although saturation of the blots could have lead to some underestimation in diabetic rats, especially in the IM base). Both the glycosylated form (35000±45000 M r ) and the non-glycosylated Expression of urea transporters. Figure 2 and 3 respectively show representative northern and western blots for the three urea transporters. As already described, UT-A1 mRNA in normal rats was abundantly expressed in the tip IM and showed only a weak expression in the base of IM. In diabetic rats, UT-A1 message increased in both parts of the IM but to a much larger extent in the base ( 2.8) than in the tip ( 1.2) (Fig. 2 and 4) . The changes in total protein (97 000 plus 117000 M r ) abundance in base and tip were similar to those in mRNA ( 3.2 and 1.5, respectively) (Fig. 4) . The 97 000 and 117000 M r isoforms of UT-A1 were not, however, influenced to the same extent in the base, and changed in opposite direction in the tip of IM. The considerable increase in total protein observed in IM base was mostly accounted for by an eightfold increase in the 117000 M r isoform whereas the 97000 M r isoform hardly changed. In the IM tip, the abundance of the 97000 M r was decreased about twofold in diabetes whereas that of the 117000 M r was more than tripled. The 117000 M r form thus became the dominant protein in the IM in diabetic rats. The opposite changes of the two isoforms suggest that part of the 97000 M r form was converted to the 117000 M r form by additional glycosylation.
UT-A2 is mainly expressed in the deep IS. Diabetic rats exhibited a decline in the three UT-A2 protein isoforms ( Fig. 3 and 4) but the corresponding message was not altered (Fig. 2 and 4) .
The mRNA of the vascular urea transporter UT-B1 was expressed in the four medullary subregions with the highest expression in the IM base (Fig. 5) .
The corresponding protein was represented in IM by two isoforms of 65 000 and 70000 M r whereas only the 65000 M r isoform was detectable in IS (Fig. 2) . Neither the mRNA nor the protein abundance of UT-B1 were influenced by diabetes (Fig. 2,  3 , and 5).
Discussion
In our study, we examined the consequences of established diabetes mellitus on the expression of AQP2 and UTs in different renal medullary zones. The results reveal that, in uncontrolled diabetic rats, the expression of two proteins critical for the vasopressindependent urinary concentrating process, AQP2 and UT-A1, is considerably increased in the renal medulla. This increase occurs in a situation characterised by an enhanced vasopressin secretion [1±3] and an increased need for water conservation. Actually, as already mentioned [9, 10] , the diabetic kidney achieves a considerable success in concentrating a large amount of glucose in the urine. This is evidenced by the 4.4-fold higher solute-free water reabsorption occurring in diabetic rats compared with control rats, even though urine flow rate is increased and urine osmolality decreased.
AQP2. Using semiquantitative immunoblotting, other investigators observed equal AQP2 abundance in total cell lysate of the tip of inner medulla in control and 3-day diabetic rats [25] . On the other hand, one preliminary report shows a significant 41 % increase in AQP2 protein in whole kidney membranes of diabetic rats [26] . Our study reveals that the increased abundance in AQP2 protein occurs in all subzones of the medulla and is much more pronounced in inner stripe than in inner medulla. Although cortex and outer stripe were not examined, it is reasonable to assume that AQP2 overexpression also occured in these zones inasmuch as the bulk of water reabsorption is known to occur in the cortical part of the collecting duct. But this overexpression could probably not be detected in cortex homogenates because col- Fig. 3 . Immunoblots of UT-A1, UT-A2, UT-B1 in homogenates from superficial and deep halves of inner stripe of outer medulla (IS), and from base and the tip of inner medulla (IM) of diabetic (DM) and control (CO) rats. Each lane was loaded with 15 mg of total protein lecting duct epithelium represents too small of a fraction of the total tissue in this zone. Moreover, this fraction is probably even smaller in diabetes because of proximal tubule hypertrophy [27] .
Up regulation of AQP2 could depend directly on the raised vasopressin level because chronic vasopressin infusion in Brattleboro rats was shown to induce a threefold increase in AQP2 protein [28, 29] . The changes in water permeability paralleled the changes in AQP2 protein abundance [28] . Thus, the great upregulation of AQ2 disclosed here most probably provides the molecular basis for the intense water reabsorption achieved in diabetic rats.
Urea transporters. The UT-A1 is essential for the initial process of medullary urea recycling by permitting urea transfer from terminal collecting duct to papillary interstitium. Another study on 3-day diabetic rats examined only the 97000 M r isoform and reported a great decrease in the tip and no change in the base of inner medulla [25] . Our study in established diabetes mellitus reveals a clearcut increase in expression UT-A1 in both the base and tip of IM. This regulation occurs most likely at the transcriptional because the abundance in mRNA is incremented in the same proportion as that of the protein in the two inner medullary subregions.
The two glycosylated isoforms of UT-A1 (97 000 and 117000 M r ) both derive from the same non-glycosylated 84000 M r protein [30] . Our work shows that, in diabetes mellitus, these two isoforms are regulated differently in the different inner medullary subregions. The 97000 M r protein was not changed in the IM base and greatly underexpressed in IM tip, as has already observed 3 days after streptozotocin injection [25] . It is noteworthy that, among a number of situations in which urinary concentrating activity is altered (alterations in protein or water intake, AVP or dDAVP (V2 agonist) infusion, furosemide treatment [31] ), diabetes mellitus is the only one that exhibits a change in the 97000 M r protein. The 117000 M r protein was greatly increased in both IM base and tip and thus in both initial and terminal IMCD. Such an increase in the 117000 M r band has been reported for total inner medulla in several cases of high urine flow rate (furosemide treatment, Brattleboro rats with diabetes insipidus, low protein diet [31] ).
The concomitant rise in the 117000 M r and fall in the 97000 M r protein isoforms suggests a shift toward a more intense glycosylation of the urea transporter. This could be responsible for a greater transport capacity because, in situations in which the 117000 M r protein was also shown to be upregulated (water loading, furosemide-induced diuresis, and low protein diet) [31] , the basal and vasopressin-stimulated urea permeabilities were also increased [32, 33] . Therefore, in diabetes, the increase in UT-A1 117000 M r protein should improve urea reabsorption along the entire IMCD, thereby improving too medullary hypertonicity.
It has been shown that UT-A2 gene expression is under the control of a promoter capable of responding to changes in tonicity [34, 35] . The UT-A2 mRNA was, however, not changed in diabetic rats. Therefore, the observed down-regulation of UT-A2 proteins should result from a post-transcriptional regulation. In the case of UT-B1, neither the mRNA nor the protein were affected in diabetes mellitus, suggesting that the amount of UT-B1 is not limiting urea movements in vasa recta.
Functional significance. The factors already known to influence urea transporter expression are those involved in the regulation of water or nitrogen excretion [13, 15, 36] . It is therefore interesting to compare the pathophysiological situation resulting from the metabolic derangements of diabetes with that induced by different concentrations of vasopressin or by alterations in protein intake.
Vasopressin secretion is increased in diabetes mellitus [1±3] and the reabsorption of solute-free water is considerably enhanced. It is thus interesting to evaluate if the changes in UT expression observed in diabetes mellitus resemble those seen in relation with increased water conservation, as induced experimentally in normal rats by chronic infusion of AVP or dDAVP. In fact, they are different. In the case of UT-A1, chronic dDAVP infusion did not induce a change in mRNA and protein expression in whole IM [31, 37] in contrast to the considerable increase seen in diabetes mellitus (present study). A recent study showed that chronic dDAVP infusion induced a shift of UT-A1 protein from the tip to the base of IM [38] . In the case of UT-A2, chronic dDAVP infusion in normal rats increased its expression in IS, whereas a fall was observed in this renal zone in diabetic rats. The regulation of UT-B1 also differs in the two cases. A decrease in mRNA abundance in IM and an increase in outer medulla were observed in dDAVP-treated Brattleboro rats [37] but no change occured in diabetic rats.
Thus, in spite of the high plasma vasopressin concentrations and large water reabsorption present in diabetes mellitus, the changes in UTs do not correspond to those observed after intense stimulation of urinary concentrating activity. In fact, an important functional difference exists between these two conditions. In diabetes mellitus, a dramatic increase in osmolar excretion occurs, largely due to glucose, and the relative concentration of urea in urine, as shown by the considerable decrease urine to plasma ratio. In contrast, chronic dDAVP infusion in normal rats is not accompanied by any change in osmolar excretion and the urine to plasma urea ratio is considerably enhanced [39] . The changes in renal urea handling seen in dDAVP-infused rats improve the capacity of the kidney to concentrate urea in the urine whereas those seen in diabetic rats are important for the concentration of glucose in the urine, not for that of urea. Note that urine to blood glucose ratio in diabetic rats reaches a value similar to urine to plasma urea ratio.
Could the changes in UTs occuring in diabetes mellitus represent an adaptation to the altered needs for nitrogen excretion? Urea excretion in diabetic rats is twice as high as in control rats. Thus, renal urea functions in diabetes mellitus could resemble that found in cases of high protein intake. Our study shows that the molecular adaptation seen in diabetes The abundance of mRNA is expressed relative to that of (b-actin. Each column represents the mean of 4±5 rats per group. No significant difference was found between DM and CO rat mellitus is different because the changes in UT mRNA and protein abundance observed in diabetes mellitus differ from those resulting from protein-rich diet (unchanged mRNA [40] , and decreased 117000 M r isoform [31] ). In contrast, some of the diabetes-induced changes resemble those induced by chronic low protein feeding, such as extension of UT-A1 mRNA [41] and vasopressin-dependent urea permeability [33, 42] to the initial part of the IMCD, increase in the 117000 M r isoform [31] , and lack of change in UT-A2 and UT-B1 mRNA abundance [40] .
At first glance, the similarity of those changes in the urea transporter expression seen in diabetes and chronic low protein feeding seem surprising because these two cases show opposite changes in urea excretory needs. The two cases share some similarities, however, because they both result in a relative deficiency in the amino acids available for metabolic needs, in the first case because of an excess of protein catabolism and in the second case because of an insufficient nitrogen supply. Overexpression of UT-A1 and its appearance in the early IMCD favour the recovery of part of the urea flowing in the collecting duct and its subsequent transfer to the gut where it can be hydrolyzed by microflora endowed with urease, thus allowing the reuse of urea nitrogen by the body [14, 15] .
Additionally, the increase of glucocorticoids in diabetes mellitus could contribute to UT-A1 changes. Others have shown that the fall in the 97 kD protein in diabetic rats was prevented by adrenalectomy and that dexamethasone replacement reversed this effect [25, 43] . They excluded insulinopenia and hyperglycaemia as possible causes for these changes [25] .
In conclusion, this study shows the molecular changes that accompany the enhanced urine concentrating activity and osmolar excretion associated with uncontrolled diabetes mellitus. The two essential transporters involved in the urinary concentrating process, AQP2 and UT-A1, are overexpressed. The increase of AVP occuring in diabetes mellitus could mediate the up regulation of AQP2 abundance but does not seem to be responsible for that of the urea transporters. The increased expression of these transporters is probably important for water conservation in view of the large amount of glucose excreted in the urine and for nitrogen conservation in view of an excess of protein catabolism.
